The biologic, serologic, and molecular properties of isolates of human immunodeficiency virus type 1 (HIV-1) from the central nervous system (CNS) were determined and compared to those of isolates from peripheral blood and lymph nodes. Among these were pairs of CNS and blood isolates obtained from six infected individuals. The data show that HIV-1 isolates from the CNS can be distinguished from peripheral blood isolates by their (i) relative inability to infect established T-cell lines, (ii) reduced cytopathogenicity, (iii) inability to modulate CD4 antigen expression on infected cells, (iv) efficient replication in peripheral blood macrophages, and (v) insensitivity to serum neutralization. Paired CNS and peripheral blood isolates from the same individual also display some differences in cellular tropism. The blood isolates replicate better in T-cell lines and glioma cell lines, whereas the paired CNS isolates replicate more efficiently in primary macrophages. These results suggest that viruses isolated from the CNS of infected individuals may represent a specific HIV-1 subgroup.
Neurological syndromes have been described in many patients with the acquired immunodeficiency syndrome (AIDS) (1) (2) (3) . These include dementia, subacute encephalitis, and vacuolar degeneration of the spinal cord. The isolation of infectious human immunodeficiency virus type 1 (HIV-1) from brain tissues and cerebrospinal fluid (CSF) of patients with the disease (4, 5) and the detection of the HIV-1 genome in the brain (6) strongly suggest that this virus is directly responsible for some of the neurological disorders found in patients with AIDS. The major cell type in the brain that shows infection by HIV-1 is the macrophage (7, 8) , although other cell types such as endothelial cells and glial cells have also been reported to be infected (8) (9) (10) (11) . This apparent "neurotropism" of HIV-1 is not surprising, since infection by other members of the lentivirus family (e.g., visna virus) also leads to neurologic disorders. However, these observations raise important questions as to whether isolates from the brain of individuals with neurologic disease constitute a specific subgroup of HIV.
Our laboratory has been able to distinguish HIV-1 strains by their ability to infect a variety of different human cells, their capacity to replicate to high titers in these cells, and their ability to induce cytopathic effects that correlate with their induction of plaques in the MT-4 cell line (10, 12, 13) . Moreover, differences in their susceptibilities to serum neutralization and in the sensitivities of their proviral DNA to restriction enzyme digestions have been observed (12, 14) . In an attempt to identify a "neurotropic" subgroup of HIV-1, the biologic, serologic, and molecular properties of HIV-1 isolates from the central nervous system (CNS) and peripheral blood were determined and compared. These included pairs of CNS and blood isolates obtained from six different infected individuals. The data suggest that HIV-1 isolates from the CNS of individuals with neurologic diseases exhibit several distinguishing properties that may reflect a specific subgroup of HIV.
MATERIALS AND METHODS Subjects Studied. The isolates used in this study (Tables 1  and 2) were initially obtained by cocultivation of peripheral blood mononuclear cells (PBMCs), lymph node, CSF, or brain biopsy specimens from HIV-1-positive patients with mitogen-stimulated PBMCs from seronegative donors, as described (4, 15) . The blood isolates examined came from randomly selected patients with different stages of HIV-1 infection. The CNS isolates were obtained from neurologic patients referred to our laboratory from 1984 to 1988 for study of HIV infection of the CNS.
Viruses and Cell Lines. All HIV-1 isolates were grown to high titers in PBMCs [i.e., reaching levels of reverse transcriptase (RT) activity of >106 cpm/mlJ and then frozen in 1-ml aliquots at -70'C for future studies. The established T-cell lines HuT 78, CEM, and Jurkat and the monocyte/ macrophage cell line U-937 were maintained in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM glutamine, and antibiotics (penicillin, 100 units/ml; streptomycin, 100 /Lg/ml) (16) . Primary monocytes were obtained from Ficoll/Hypaque gradientpurified PBMCs by the plastic-adherence technique (12, 17) .
To allow for differentiation into macrophages, these cells were cultured for 10-12 days in RPMI 1640 medium supplemented with 10% FBS, 5% heat-inactivated human serum, and antibiotics before infection with HIV-1. The glioma cell lines (U251, U343MGA), obtained from M. Rosenblum (University of California, San Francisco), were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS and antibiotics (18) .
HIV-1 Infection. The T-cell and monocytic cell lines were infected with HIV-1 isolates, as previously described (16) . For infection of peripheral blood macrophages, the cells were treated with Polybrene (2 ,ug/ml) for 30 min at 370C and exposed to virus-containing fluids for 1 hr at 370C. Cells were then washed three times and maintained in culture medium. Infection ofglioma cell lines was performed as described (18) . In brief, the monolayer cells were treated with 2 ml of DEAE-dextran (25 gg/ml) for The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. cocultivated cells were harvested at 3-to 4-day intervals and assayed for RT activity (19) . The presence of HIV-1 was confirmed by identification of viral antigens in infected cells by an indirect immunofluorescence assay (20) or immunoblot analysis (21) or by a p24 HIV-1 core antigen ELISA (DuPont). CD4 expression on the surface of infected and uninfected cells was measured by flow cytometry (16) . Serum Neutralization. Serum neutralization was performed as described (14) . In brief, serial dilutions of the heatinactivated (560C, 30 min) HIV-1 antibody-positive serum were incubated with equal amounts of virus-containing fluids (RT activity, 105 cpm) for 1 hr at room temperature. The mixture was then inoculated onto PBMCs that were pretreated with Polybrene (2 Qtg/ml). Control cultures received virus incubated with sera from antibody-negative healthy donors. Culture supernatant fluids were assayed for RT activity at 3-to 4-day intervals. A 67% reduction in RT level, as compared to control cultures, was considered indicative of neutralization.
Southern Blot Analysis. High molecular weight DNA from 108 HIV-infected PBMCs was prepared (22) and digested with restriction enzymes under conditions specified by the supplier (Boehringer Mannheim). The restricted DNA fragments were separated by electrophoresis in 0.8% agarose and blotted onto nitrocellulose membranes, and the viral species were detected by hybridization with a 32P-labeled probe representing the entire HIV-1SF2 genome (12). Proc. Natl. Acad. Sci. USA 86 (1989) in the MT-4 cells. Plaque-forming ability of an HIV-1 isolate has been shown to correlate with its ability to grow rapidly and to induce cytopathology in PBMCs and the MT-4 cell line (13) . Further, all five of the cytopathic lymphocyte isolates reduced the expression of the surface CD4 receptor molecule on the infected cells. Finally, as previously reported (14) , all the lymphocyte isolates were easily neutralized by sera from HIV-1 positive individuals at titers of -1:100.
In contrast, only one of the five CNS isolates (HIV-lSF301a) replicated in the human T-cell lines, whereas three of the five isolates (HIV-lSF98, HIV-lSF162, HIV-lSF178) replicated efficiently in primary macrophages. None of the isolates induced plaques in the MT-4 cell line and only HIV-1SF301a produced cytopathic effects in infected CD4' lymphocytes concomitant with a reduction in surface CD4 antigen expression. The other brain isolates replicated substantially in CD4' cells, but there was no evidence of cytopathic effect in these cells nor a modulation in CD4 expression. All CNS isolates, except HIV-1sF301a, were resistant to serum neutralization. HIV1SF301a was easily neutralized by HIV-1-positive sera at titers of >1:100.
Comparison of Blood and CNS Isolates Obtained from the Same Individual. To examine further the possibility that HIV brain isolates constitute a separate virus subgroup, HIV-1 strains recovered from the blood and CNS of the same individual were examined. Table 4 summarizes the biologic properties of these paired blood and CNS isolates. Three of the six paired blood isolates (from subjects C, D, and F) replicated in at least one of the T-cell lines, whereas none of the paired CNS isolates established a productive infection in these cells. When replication in macrophages was examined, all the isolates productively infected primary peripheral blood macrophages. However, the CNS isolates from subjects A-D replicated with faster kinetics and the virus titers from the infected macrophages were 5-to 10-fold higher than those obtained with their paired blood isolates (Fig. 1A) . Moreover, only the CNS isolate from subject D productively infected the U-937 monocytic cell line (data not shown). The ability of the paired isolates to infect two astrocytoma cell lines was also examined. In these cells, cocultivation of the infected glioma cells with PBMCs from seronegative individuals is necessary to detect HIV-1 replication (18) . The blood isolates from subjects A, C, and D replicated more efficiently than their paired CNS isolates. This finding was again reflected both in the kinetics of replication and in titers of virus recovered (Fig. 1B) . None of the blood or CNS paired isolates induced plaques in the MT-4 cell line, indicating that they are relatively noncytopathic (13) . Further, these isolates did not modulate CD4 antigen expression on CD4' lymphocytes and were not sensitive to neutralization by the HIV-1 antibody-positive sera used in these studies. Moreover, in two cases in which autologous sera were available for serum neutralization (subjects A and D), no difference in sensitivity to serum neutralization of CNS and blood isolates was observed; both isolates were neutralized at serum titers of 1:10. Thus, the paired isolates appeared to be similar antigenically and resembled primarily HIV-1 isolates from patients with neurologic disorders (Table 3) . Nevertheless, the data indicate that CNS and blood isolates obtained from the same individual can display differences in host range tropism.
To determine whether these paired isolates are genomically related or distinct viruses, restriction endonuclease digestion analysis was performed on infected cellular DNA. Fig. 2 shows Southern blot analyses of two pairs of blood and CNS isolates. The restriction enzyme digestion patterns of these paired isolates are very similar. Minor differences were observed with some restriction endonucleases, but these differences could be accounted for by the gain or loss of a restriction site. For example, a gain of a Pv'ii II site was seen in the HIV-1SF128B strain as compared to HIV-1SFl1xA for subject A (Fig. 2A) ; a gain of a Sal I site in HIV-1SF92lB was observed when compared to HIV-1sF92lA from subject C (Fig. 2B) . Similar observations were made with restriction endonuclease studies performed on the other paired isolates (data not shown). The results show that blood and CNS isolates obtained from the same individual are genotypically related strains of HIV-1.
DISCUSSION
A set of biologic and serologic properties that distinguish individual HIV-1 strains was used to examine whether isolates from the CNS might constitute a distinct subgroup of HIV-1. Randomly selected peripheral blood isolates obtained from infected individuals without neurologic disorders and HIV-1 recovered from the CNS of patients referred for neurologic examinations (Table 1) were studied. In comparison to HIV-1 recovered from the blood, the CNS isolates are less cytopathic, do not replicate in established human T-cell lines, and display a greater tropism for primary peripheral blood macrophages (Table 3) . That isolates from the CNS are less cytopathic and replicate better in primary monocyte/ macrophages than do blood isolates has been reported by others (17, 25) . In addition, we found that the CNS-derived HIV-1 strains do not reduce the expression of the CD4 receptor molecule on infected peripheral blood CD4' lymphocytes despite substantial replication in these cells, and these viruses are less susceptible to serum neutralization. Exceptions in our study were found for both a lymphocyte (HIV-lSF1l3) and a CNS (HIV-lSF3Ola) Results with paired CNS and PBMC isolates obtained from the same individual support these conclusions on distinguishing properties of HIV-1 strains recovered from the blood and brain. Differences both in kinetics of replication and in levels of virus production were noted in the ability of paired isolates to infect primary peripheral blood macrophages, T-cell lines, and glioma cell lines bearing glial fibrillary acid protein, a marker specific for astrocytes (18) (Table 4 ). The CNS isolates replicated better in primary peripheral blood macrophages, whereas the blood isolates infected T-cell lines and glial cells more efficiently. Since the paired isolates appeared to be genomically related (Fig. 2) , these findings suggest that in individuals with neurologic disorders, the presence of variants of one HIV-1 strain with different biologic properties is likely. Similar differences in cellular tropism have been reported for HIV-1 isolates obtained from the CSF and brain tissues of the same individual (26) . The isolate from the brain efficiently infected primary peripheral blood monocyte/ macrophages, whereas the virus from the CSF productively infected a glioma cell line. These isolates, however, were genotypically distinct virus strains (26 (7, 8) . This observation has led some investigators to cite the macrophage as a source of entry and pathogenic effects of HIV in the CNS (1, 7, 27, 28) . However, in situ hybridization and immunocytochemical studies of brain tissues from infected individuals, together with in vitro infection studies, suggest that HIV-1 also infects endothelial and glial cells (8-11, 18, 29-31) . Further, our observation that the paired blood isolates infected glial cells more efficiently than CNS isolates raises the possibility that blood-borne HIV-1 strains enter the brain through infection of these cell types. Subsequently, from the glial cells, these HIV-1 could spread or generate variants that infect other In summary, our data suggest that CNS isolates obtained from individuals with neurologic disorders share properties defined by cell tropism, cytopathology, and antigenicity that distinguish them from the predominant HIV-1 strains derived from blood of individuals without neurologic disease. This conclusion is supported as well by relative differences in cellular tropism observed in blood and CNS isolates obtained from the same individual with neurologic disorders. How this subgroup of HIV-1 is generated or emerges in the host merits further investigation.
